`
`
`
`
`
`PTO-1390 (03-13)
`
`
`Approved for use through 4/30/2013. 0MB 0651-0021
`
`
`
`
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`
`
`
`
`
`
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid 0MB control number.
`
`Attorney Docket No.
`TRANSMITTAL LETTER TO THE UNITED STATES
`
`
`
`0112-301/C03308 US1
`
`DESIGNATED/ELECTED OFFICE (DO/EO/US)
`
`
`
`CONCERNING A SUBMISSION UNDER 35 U.S.C. 371
`Priority Date Claimed
`
`
`International Application No.
`
`
`nternational Filing Date
`
`PCT/EP2014/061350
`June 2, 2014
`June 3, 2013
`Title of Invention
`
`Reconfigurable Output Stage
`First Named Inventor
`
`Philippe SI RITO-OLIVI ER
`
`U.S. Application No. (if known, see 37 CFR 1.5)
`
`II
`
`1. 0
`
`
`
`phase under PCT Rule 4.17(iv).b. D was previously filed in the international
`
`
`
`Items 5 to 8 below concern amendments made in the international phase.
`
`
`
`Amendments to the claims under PCT Article 19 are attached (not required if communicated by the International Bureau) (35 U.S.C.
`
`
`
`
`
`
`
`
`
`English translation of the PCT Article 19 amendment is attached (35 U.S.C. 371 (c)(3)).
`
`
`
`English translation of annexes (Article 19 and/or 34 amendments only) of the International Preliminary Examination Report is
`
`Applicant herewith submits to the United States Designated/Elected Office (D0/EO/US) the following items and other information.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`This is an express request to begin national examination procedures (35 U.S.C. 371 (f)). NOTE: The express request under
`
`
`
`
`
`
`35 U.S.C. 371 (f) will not be effective unless the requirements under 35 U.S.C. 371 (c)(1 ), (2), and (4) for payment of the basic national
`
`
`
`
`
`
`
`
`fee, copy of the International Application and English translation thereof (if required), and the oath or declaration of the inventor(s)
`
`have been received.
`A copy of the International Application (35 U.S.C. 371 (c)(2)) is attached hereto (not required if the International Application was
`
`
`
`
`
`
`
`
`
`
`2.0
`
`
`
`
`
`
`previously communicated by the International Bureau or was filed in the United States Receiving Office (RO/US)).
`
`
`
`
`
`
`An English language translation of the International Application (35 U.S.C. 371 (c)(2))
`3.
`a.D is attached hereto.
`
`154(d)(4).submitted under 35 U.S.C. b. D has been previously
`
`
`
`
`
`
`
`4. An oath or declaration of the inventor(s) (35 U.S.C. 371 (c)(4))
`a.D is attached.
`
`
`
`
`
`
`
`PCT Article 19 and 34 amendments
`
`
`5.
`□
`371 (c)(3)).
`6.
`
`
`
`□
`7.
`
`
`
`
`
`□
`
`attached (35 U.S.C. 371 (c)(5)).
`
`
`
`Cancellation of amendments made in the international phase
`
`
`
`
`
`
`
`19. phase under PCT Article 8a. D Do not enter the amendment made in the international
`
`
`
`
`
`
`34. phase under PCT Article 8b. D Do not enter the amendment made in the international
`
`
`
`
`
`
`
`
`instruction from applicant not to enter the amendment(s).
`
`
`
`NOTE: A proper amendment made in English under Article 19 or 34 will be entered in the U.S. national phase application absent a clear
`
`The following items 9 to 17 concern a document(s) or information included.
`
`Disclosure Statement under 37 CFR 1.97 and 1.98.
`
`
`
`9.0 An Information
`
`
`10. 0 A preliminary
`amendment.
`
`
`37 CFR 1. 76.11. 0 An Application Data Sheet under
`
`
`
`
`
`include claims. See 37 CFR 1.125(b). 12. D A substitute specification. NOTE: A substitute specification cannot
`
`13. D A power of attorney
`
`
`and/or change of address letter.
`
`
`
`
`
`
`
`with PCT Rule 13ter.3 and 37 CFR 1.821-1.825. 14.D A computer-readable form of the sequence listing in accordance
`
`
`15. D Assignment
`
`papers (cover sheet and document(s)). Name of Assignee: _____________________
`
`
`
`(when there is an Assignee).16. D 37 CFR 3.73(c) Statement
`
`
`
`This collection of information Is required by 37 CFR 1.414 and 1.491-1.492. The information Is required to obtain or retain a benefit by the public, which Is to file
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`(and by the US PTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.11 and 1.14. This collection is estimated to take 15
`
`
`
`
`
`
`
`
`
`
`minutes to complete, including gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual
`
`
`
`
`
`
`
`
`case. Any comments on the amount of time you require to complete this form and/or suggestions for reducing this burden should be sent to the Chief Information
`
`
`
`
`
`
`
`
`Officer, U.S. Patent and Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED
`
`
`
`
`
`FORMS TO THIS ADDRESS. SEND TO: Mail Stop PCT, Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`
`IPR2022-00716
`Apple EX1002 Page 1
`
`

`

`PT0-1390 (03-13)
`
`
`
`
`Approved for use through 4/30/2013. 0MB 0651-0021
`
`
`
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`
`
`
`
`
`
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid 0MB control number.
`
`
`
`
`
`U.S. APPLN. No. (if known - see 37 CFR 1.5)
`
`
`INTERNATIONAL APPLICATION No.
`ATTORNEY DOCKET No.
`PCT/EP2O14/O6135O 0112-301 /CO33O8 US1
`17.
`Other items or information:
`0
`
`CALCULATIONS PTO USE ONLY
`
`
`The following fees have been submitted.
`1s.0 Basic national
`fee (37 CFR 1.492(a)) ...............................................
`
`
`$280 $280.00
`19.0 Examination fee (37 CFR 1.492(c))
`
`
`If the written opinion prepared by ISA/US or the international preliminary
`
`
`
`
`
`
`
`
`of $ 720.00 examination report prepared by IPEA/US indicates all claims satisfy provisions
`
`
`
`PCT Article 33(1)-(4) .................................................................... $0
`
`
`
`
`All other situations ....................................................................... $720
`
`20. 0 Search fee (37 CFR 1.492(b))
`If the written opinion prepared by ISA/US or the international preliminary
`
`
`
`
`
`
`
`
`
`
`examination report prepared by IPEA/US indicates all claims satisfy provisions of
`
`
`
`PCT Article 33(1)-(4) .................................................................... $0
`
`
`
`
`
`Search fee (37 CFR 1.445(a)(2)) has been paid on the international application to
`$ 480.00
`
`
`
`
`the US PTO as an International Searching Authority ............................ $120
`
`
`
`
`
`
`International Search Report prepared by an ISA other than the US and provided to
`
`
`
`
`the Office or previously communicated to the US by the IB ................... $480
`
`
`
`
`All other situations ........................................................................ $600
`
`and 20 = $ 1,480.00
`TOTAL OF 18, 19,
`dditional fee for specification and drawings filed in paper over 100 sheets
`
`
`
`
`
`
`
`
`(excluding sequence listing in compliance with 37 CFR 1.821 (c) or (e) in an
`
`
`
`
`electronic medium or computer program listing in an electronic medium) (37 CFR
`1.492U)).
`
`
`
`
`Fee for each additional 50 sheets of paper or fraction thereof ............... $400
`
`Total Sheets Extra Sheets Number of each addition 50 or fractionRATE
`
`
`thereof (round up to a whole number)
`-100 =
`I 50 =
`x$400 $
`
`Surcharge of $140.00 for furnishing any of the search fee, examination fee, or the oath or $
`
`
`
`
`
`
`declaration after the date of commencement of the national stage (37 CFR 1.492(h)).
`CLAIMS NUMBER FILED NUMBER EXTRA
`RATE
`Total claims
`15 -20 =
`X $80 $ 0.00
`0
`
`Independent claims 1 - 3 = 0
`X $420 $0.00
`
`MULTIPLE DEPENDENT CLAIM(S) (if applicable)
`$
`
`
`
`
`
`Processing fee of $140.00 for furnishing the English translation later than 30 months from the $
`
`
`earliest claimed priority date (37 CFR 1.492(i)).
`= $ 0.00
`
`TOTAL OF ABOVE CALCULATIONS
`See 37 CFR pplicant asserts small entity status. 1.27. Fees above are reduced by½.
`
`
`
`
`
`
`See 37 CFR 1.29. pplicant certifies micro entity status. Fees above are reduced by¾.
`
`
`
`
`Applicant must attach form PTO/SB/15A or B or equivalent.
`
`
`
`+ $780
`
`+
`
`□A
`
`□A
`
`□A
`
`
`
`
`
`FEE = $1,480.00
`TOT AL NATIONAL
`
`
`
`
`
`Fee for recording the enclosed assignment (37 CFR 1.21 (h)). The assignment must be
`$
`
`
`accompanied by an aooropriate cover sheet (37 CFR 3.28, 3.31 ). $40.00 per property. +
`
`TOTAL FEES ENCLOSED= $1,480.00
`Amount to be $
`refunded:
`Amount to be $
`charged:
`
`[Page 2 of 3]
`
`IPR2022-00716
`Apple EX1002 Page 2
`
`

`

`PTO-1390 (03-13)
`
`
`Approved for use through 4/30/2013. 0MB 0651-0021
`
`
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`
`
`
`
`
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid 0MB control number.
`
`
`
`
`
`
`
`a.
`to cover the above fees is enclosed.
`
`□A check in the amount of$
`
`b.
`to cover the above fees.
`□Please charge my Deposit Account No.
`
`
`in the amount of $
`
`
`
`
`
`overpayment, to Deposit Accountfees which may be required, or credit any to charge additional 0 The Director is hereby authorized
`No. 50-5835
`as follows:
`
`i. 0 any required fee.
`feeand (e) and multiple dependent claim under 37 CFR 1.492(d) excess claims fees required ii.□ any required fee except for
`
`
`
`
`
`
`required under 37 CFR 1.492(f).
`
`
`
`
`
`card. WARNING: Information on this form may become public. Credit card information should not
`□Fees are to be charged to a credit
`d.
`
`
`
`
`
`
`
`
`be included on this form. Provide credit card information and authorization on PTO-2038. The PTO-2038 should only be mailed or
`
`
`
`
`
`
`faxed to the US PTO. However, when paying the basic national fee, the PTO-2038 may NOT be faxed to the USPTO.
`
`
`
`
`
`
`ADVISORY: If filing by EFS-Web, do NOT attach the PTO-2038 form as a PDF along with your EFS-Web submission. Please be
`
`
`
`
`
`
`
`To protect yourvia PAIR. may be displayed card information advised that this is not recommended and by doing so your credit
`
`
`
`
`information, it is recommended to pay fees online by using the electronic payment method.
`
`
`
`
`
`NOTE: Where an appropriate time limit under 37 CFR 1.495 has not been met, a petition to revive (37 CFR 1.137(a) or (b)) must be
`
`
`
`
`filed and granted to restore the International Application to pending status.
`
`
`
`
`Statement under 37 CFR 1.55 or 1. 78 for AIA (First Inventor to File )Transition Applications
`contained at March 16, 2013, and (2) also contains, or of an application filed before to or the benefit □This application (1) claims priority
`
`
`
`
`
`
`
`
`
`
`
`any time, a claim to a claimed invention that has an effective filing date on or after March 16, 2013.
`
`
`
`
`
`
`
`NOTE: A U.S. national stage application may not claim priority to the international application of which it is the national phase. The filing date
`
`
`
`
`
`
`of a U.S. national stage application is the international filing date. See 35 U.S.C. 363.
`
`Correspondence Address
`
`
`
`
`0 The address associated with Customer Number: 113648
`Name I
`Address
`City I
`Country
`Email
`
`C.
`
`
`
`OR D Correspondence address below
`
`IState I
`
`IZip Code I
`ITelephone I
`
`Signature
`listevenmdubois/
`�p���Type) I Steven M. du Bois
`
`Date I November 9, 2015
`
`Registration No. 135 023
`(Attorney/Agent)
`,
`
`[Page 3 of 3]
`
`IPR2022-00716
`Apple EX1002 Page 3
`
`

`

`
`
`Privacy Act Statement
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your
`
`
`
`
`
`
`submission of the attached form related to a patent application or patent. Accordingly, pursuant to the requirements of
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`the Act, please be advised that: (1) the general authority for the collection of this information is 35 U.S.C. 2(b)(2); (2)
`
`
`
`
`
`
`furnishing of the information solicited is voluntary; and (3) the principal purpose for which the information is used by the
`
`
`
`
`
`
`U.S. Patent and Trademark Office is to process and/or examine your submission related to a patent application or
`
`
`
`
`
`
`
`patent. If you do not furnish the requested information, the U.S. Patent and Trademark Office may not be able to
`
`
`
`
`
`
`process and/or examine your submission, which may result in termination of proceedings or abandonment of the
`
`
`application or expiration of the patent.
`
`
`
`
`
`
`
`
`
`
`
`
`
`The information provided by you in this form will be subject to the following routine uses:
`
`
`
`1. The information on this form will be treated confidentially to the extent allowed under the Freedom of
`
`
`
`
`
`
`
`
`Information Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C 552a). Records from this system of records may
`
`
`
`
`
`
`
`be disclosed to the Department of Justice to determine whether disclosure of these records is required by the
`
`Freedom of Information Act.
`2. A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence
`
`
`
`
`
`
`
`
`
`
`
`
`to a court, magistrate, or administrative tribunal, including disclosures to opposing counsel in the course of
`
`settlement negotiations.
`3.A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting a
`
`
`
`
`
`
`
`
`
`
`
`request involving an individual, to whom the record pertains, when the individual has requested assistance from
`
`
`the Member with respect to the subject matter of the record.
`4.A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency having
`
`
`
`
`
`
`
`
`
`
`need for the information in order to perform a contract. Recipients of information shall be required to comply
`
`
`
`
`with the requirements of the Privacy Act of 1974, as amended, pursuant to 5 U.S.C. 552a(m).
`
`
`
`
`5. A record related to an International Application filed under the Patent Cooperation Treaty in this system of
`
`
`
`
`
`records may be disclosed, as a routine use, to the International Bureau of the World Intellectual Property
`
`
`
`Organization, pursuant to the Patent Cooperation Treaty.
`6.A record in this system of records may be disclosed, as a routine use, to another federal agency for purposes
`
`
`
`
`
`
`
`
`
`of National Security review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C.
`218(c)).
`7.A record from this system of records may be disclosed, as a routine use, to the Administrator, General
`
`
`
`
`
`
`
`
`
`
`Services, or his/her designee, during an inspection of records conducted by GSA as part of that agency's
`
`
`
`
`
`
`
`
`responsibility to recommend improvements in records management practices and programs, under authority of
`
`
`
`
`
`44 U.S.C. 2904 and 2906. Such disclosure shall be made in accordance with the GSA regulations governing
`
`
`
`
`
`
`inspection of records for this purpose, and any other relevant GSA or Commerce) directive. Such
`(i.e.,
`
`
`disclosure shall not be used to make determinations about individuals.
`8. A record from this system of records may be disclosed, as a routine use, to the public after either publication of
`
`
`
`
`
`
`
`
`
`
`
`
`the application pursuant to 35 U .S.C. 122(b) or issuance of a patent pursuant to 35 U .S.C. 151. Further, a
`
`
`
`
`record may be disclosed, subject to the limitations of 37 CFR 1.14, as a routine use, to the public if the record
`
`
`
`
`was filed in an application which became abandoned or in which the proceedings were terminated and which
`
`
`
`
`
`
`
`
`application is referenced by either a published application, an application open to public inspection or an issued
`patent.
`9. A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law
`
`
`
`
`
`
`
`
`enforcement agency, if the USPTO becomes aware of a violation or potential violation of law or regulation.
`
`IPR2022-00716
`Apple EX1002 Page 4
`
`

`

`(07-14)
`PTO/AIN14
`
`Approved for use through 04/3012017. 0MB 0651-0032
`
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`
`
`
`
`
`are required lo respond to a collection of information unless it contains a valid 0MB control number.
`Act of 1995, no persons
`Under the Paperwork Reduction
`
`
`
`Attorney Docket Number 0112-301/C03308 US1
`
`
`
`Data Sheet 37 CFR 1.76 Application Application Number
`Title of Invention Reconfigurable Output Stage
`
`The application data sheet is part of the provisional or nonprovisional application for which it is being submitted. The following form contains the
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`bibliographic data arranged in a format specified by the United States Patent and Trademark Office as outlined in 37 CFR 1. 76.
`
`
`
`
`
`
`
`
`This document may be completed electronically and submitted to the Office in electronic format using the Electronic Filing System (EFS) or the
`
`
`
`
`document may be printed and included in a paper filed application.
`
`Secrecy Order 37 CFR 5.2
`Portions or all of the application associated with this Application Data Sheet may fall under a Secrecy Order pursuant to
`
`
`
`
`
`37 CFR 5.2 (Paper filers only. Applications that fall under Secrecy Order may not be filed electronically.)
`D
`
`
`
`Inventor Information:
`
`Inventor 1
`Legal Name
`
`Remove
`I
`I
`
`Prefix Given Name
`Philippe
`
`Residence Information (Select
`
`Middle Name
`
`City Saint Eg reve
`
`Family Name
`SIRITO-OLIVIER
`One) 0 US Residency ® Non US Residency O Active US Military Service
`
`!country of Residence i
`
`IFR
`
`Suffix
`
`
`
`Mailing Address of Inventor:
`
`
`Address 1
`
`
`
`2bis rue de Bellevue Pare symphonie 13
`
`Address 2
`Saint Egreve
`City I
`F-38120
`Postal Code I
`Inventor 2
`Legal Name
`
`I State/ProvinceI
`FR
`I Country i I
`
`
`IRemove I
`
`Prefix Given Name
`Family Name
`Patrizia
`MILAZZO
`
`
`
`Residence Information (Select
`City S.Agata Li Battiati
`!country of Residence i
`
`I IT
`
`Middle Name
`
`Suffix
`
`One) 0 US Residency ® Non US Residency 0 Active US Military Service
`
`
`
`Mailing Address of Inventor:
`Via J.F. Kennedy 23
`
`Address 1
`
`Address 2
`S. Agata Li Battiati
`City I
`1-95030
`Postal Code I
`Inventor 3
`Legal Name
`
`EFS Web 2.2.12
`
`I State/ProvinceI
`IT
`I Country i I
`
`Remove
`I
`I
`
`IPR2022-00716
`Apple EX1002 Page 5
`
`

`

`PTO/AIN14 (07-14)
`
`
`Approved for use through 04/3012017. 0MB 0651-0032
`
`
`
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`
`
`
`
`
`Under the Paperwork Reduction Act of 1995, no persons are required lo respond to a collection of information unless it contains a valid 0MB control number.
`
`
`
`
`
`
`
`
`
`
`Data Sheet 37 CFR 1.76 Application Number Application
`Title of Invention Reconfigurable Output Stage
`
`
`Attorney Docket Number 0112-301/C03308 US1
`
`Middle Name
`
`Suffix
`
`Prefix Given Name
`Angelo
`
`
`City Grenoble
`
`Residence Information (Select
`
`Family Name
`NAGARI
`
`!country of Residence i
`I FR
`
`One) 0 US Residency (e) Non US Residency 0 Active US Military Service
`
`
`
`Mailing Address of Inventor:
`12 Rue de la Poste
`
`Address 1
`
`Address 2
`
`City I Grenoble
`I State/ProvinceI
`I Country i I FR
`Postal Code I F-38000
`
`All Inventors Must Be Listed -Additional Inventor Information blocks may be
`
`
`
`
`generated within this form by selecting the Add button.
`
`Add
`
`I
`
`I
`
`
`
`Correspondence Information:
`
`Enter either Customer Number or complete the Correspondence Information section below.
`
`
`
`
`
`
`
`
`For further information see 37 CFR 1.33(a).
`
`
`D An Address is being provided for the correspondence
`Number 113648
`Customer
`Email Address
`
`I I Add Email I
`
`!Remove Emaill
`
`
`
`
`Information of this application.
`
`Application Information:
`
`
`Title of the Invention Reconfigurable Output Stage
`
`Docket Number 0112-301/C03308 US1 I Small Entity Status
`Attorney
`Nonprovisional
`
`Application Type
`Utility
`
`Subject Matter
`Total Number of Drawing Sheets (if any) I 4
`
`
`Filing By Reference :
`Only complete this section when filing an application by reference under 35 U.S.C. 111 (c) and 37 CFR 1.57(a). Do not complete this section if
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`application papers including a specification and any drawings are being filed. Any domestic benefit or foreign priority information must be
`
`
`
`
`
`
`
`
`
`provided in the appropriate section(s) below (i.e., uDomestic Benefit/National Stage Information• and "Foreign Priority Information").
`
`
`
`
`
`
`
`
`
`For the purposes of a filing date under 37 CFR 1.53(b), the description and any drawings of the present application are replaced by this
`
`
`
`
`
`
`reference to the previously filed application, subject to conditions and requirements of 37 CFR 1.57(a).
`Intellectual Property Authority or Country i-
`
`
`
`Application number of the previously Filing date (YYYY-MM-DD)
`
`filed application
`
`Claimed
`□
`
`I Suggested
`Figure for Publication
`
`(if any) I 2
`
`
`
`EFS Web 2.2.12
`
`IPR2022-00716
`Apple EX1002 Page 6
`
`

`

`
`
`
`
`
`
`PTO/AIN14 (07-14)
`
`
`Approved for use through 04/3012017. 0MB 0651-0032
`
`
`
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`
`
`
`
`
`Under the Paperwork Reduction Act of 1995, no persons are required lo respond to a collection of information unless it contains a valid 0MB control number.
`Attorney Docket Number 0112-301/C03308 US1
`
`
`Application Data Sheet 37 CFR 1.76
`Application Number
`
`
`
`
`
`Title of Invention Reconfigurable Output Stage
`
`Pub I ication Information:
`
`
`D Request Early Publication (Fee required at time of Request 37 CFR 1.219)
`
`
`
`I hereby request that the attached application not be published under
`Request Not to Publish.
`
`
`application has not and will not be theD 35 U.S.C. 122(b) and certify that the invention disclosed in the attached
`
`
`
`
`
`
`subject of an application filed in another country, or under a multilateral international agreement, that requires
`publication at eighteen months after filing.
`
`
`
`Representative Information:
`
`Representative information should be provided for all practitioners having a power of attorney in the application. Providing
`
`
`
`
`
`
`
`
`
`
`
`this information in the Application Data Sheet does not constitute a power of attorney in the application (see 37 CFR 1.32).
`
`
`
`
`
`
`
`Either enter Customer Number or complete the Representative Name section below. If both sections are completed the customer
`
`
`
`Number will be used for the Representative Information during processing.
`
`Please Select One: ® Customer Number I O US Patent
`
`Practitioner 10 Limited Recognition
`
`Customer Number 113648
`
`
`
`(37 CFR 11.9)
`
`Domestic Benefit/National Stage Information:
`
`
`
`This section allows for the applicant to either claim benefit under 35 U.S.C. 119(e), 120, 121, 365(c), or 386(c) or indicate National
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Stage entry from a PCT application. Providing this information in the application data sheet constitutes the specific reference
`
`
`required by 35 U.S.C. 119(e) or 120, and 37 CFR 1.78.
`
`
`
`
`
`When referring to the current application, please leave the application number blank.
`
`IRemove I
`Prior Application Status
`Prior Application Number Filing Date (YYYY-MM-DD)
`Continuity Type
`Application Number
`a 371 of international PCT/EP2014/061350 2014-06-02
`
`
`Additional Domestic Benefit/National Stage Data may be generated within this form
`by selecting the Add button.
`
`Add
`
`I
`
`I
`
`
`
`
`
`Foreign Priority Information:
`
`This section allows for the applicant to claim priority to a foreign application. Providing this information in the application data sheet
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`constitutes the claim for priority as required by 35 U.S.C. 119(b) and 37 CFR 1.55. When priority is claimed to a foreign application
`
`
`
`
`
`
`
`that is eligible for retrieval under the priority document exchange program (POX) �he information will be used by the Office to
`
`
`
`
`
`automatically attempt retrieval pursuant to 37 CFR 1.55(i)(1) and (2). Under the POX program, applicant bears the ultimate
`
`
`
`
`
`
`
`responsibility for ensuring that a copy of the foreign application is received by the Office from the participating foreign intellectual
`
`
`
`
`
`
`
`
`
`
`property office, or a certified copy of the foreign priority application is filed, within the time period specified in 37 CFR 1.55(g)( 1 ).
`
`Application Number
`13305740.6
`EP
`
`Country i
`
`Remove
`I
`I
`Filing Date (YYYY-MM-DD) Access Codei (if applicable)
`2013-06-03
`
`EFS Web 2.2.12
`
`IPR2022-00716
`Apple EX1002 Page 7
`
`

`

`PTO/AIN14 (07-14)
`
`
`Approved for use through 04/3012017. 0MB 0651-0032
`
`
`
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`
`
`
`
`
`Under the Paperwork Reduction Act of 1995, no persons are required lo respond to a collection of information unless it contains a valid 0MB control number.
`
`
`
`
`
`
`
`
`Application Data Sheet 37 CFR 1.76
`
`
`Attorney Docket Number 0112-301/C03308 US1
`
`
`
`Application Number
`
`
`
`Title of Invention Reconfigurable Output Stage
`
`
`
`
`
`Additional Foreign Priority Data may be generated within this form by selecting the
`
`
`
`
`Add button.
`
`Add
`
`Statement under 37 CFR 1.55 or 1. 78 for AIA (First Inventor to File) Transition
`
`
`
`Applications
`
`This application (1} claims priority to or the benefit of an application filed before March 16, 2013 and (2) also
`
`
`
`
`
`
`
`
`
`
`contains, or contained at any time, a claim to a claimed invention that has an effective filing date on or after March
`□16, 2013.
`
`
`
`
`
`
`
`
`16, 2013, will be examined under the first inventor to file provisions of the AIA.
`
`NOTE: By providing this statement under 37 CFR 1.55 or 1.78, this application, with a filing date on or after March
`
`
`
`Authorization to Permit Access:
`
`
`
`
`
`
`
`
`
`18] Authorization to Permit Access to the Instant Application by the Participating Offices
`
`If checked, the undersigned hereby grants the USPTO authority to provide the European Patent Office {EPO),
`
`
`
`
`
`
`
`
`
`the Japan Patent Office {JPO), the Korean Intellectual Property Office (KIPO), the World Intellectual Property Office (WIPO),
`
`
`
`
`
`
`
`
`
`
`and any other intellectual property offices in which a foreign application claiming priority to the instant patent application
`
`
`
`
`
`
`is filed access to the instant patent application. See 37 CFR 1.14{c) and (h). This box should not be checked if the applicant
`
`
`
`
`
`
`does not wish the EPO, JPO, KIPO, WIPO, or other intellectual property office in which a foreign application claiming priority
`
`
`
`
`
`to the instant patent application is filed to have access to the instant patent application.
`
`In accordance with 37 CFR 1.14(h)(3), access will be provided to a copy of the instant patent application with respect
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`to: 1) the instant patent application-as-filed; 2) any foreign application to which the instant patent application
`
`
`
`
`
`
`
`
`
`claims priority under 35 U.S.C. 119(a)-(d) if a copy of the foreign application that satisfies the certified copy requirement of
`
`
`
`
`
`
`
`37 CFR 1.55 has been filed in the instant patent application; and 3) any U.S. application-as-filed from which benefit is
`
`
`sought in the instant patent application.
`
`
`
`In accordance with 37 CFR 1.14(c), access may be provided to information concerning the date o f filing this Authorization.
`
`
`
`
`
`
`
`
`
`
`
`
`
`Applicant Information:
`
`
`
`Providing assignment information in this section does not substitute for compliance with any requirement of part 3 of Title 37 of CFR
`
`
`
`
`
`
`
`
`
`to have an assignment recorded by the Office.
`
`EFS Web 2.2.12
`
`IPR2022-00716
`Apple EX1002 Page 8
`
`

`

`PTO/AIN14 (07-14)
`
`
`Approved for use through 04/3012017. 0MB 0651-0032
`
`
`
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`
`
`
`
`
`Under the Paperwork Reduction Act of 1995, no persons are required lo respond to a collection of information unless it contains a valid 0MB control number.
`
`
`
`
`
`
`
`
`Application Data Sheet 37 CFR 1.76
`
`
`Attorney Docket Number 0112-301/C03308 US1
`
`
`
`Application Number
`
`
`Title of Invention
`
`Reconfigurable Output Stage
`
`Applicant
`1
`If the applicant is the inventor {or the remaining joint inventor or inventors under 37 CFR 1.45), this section should not be completed.
`
`
`
`
`
`
`
`
`
`
`
`
`The information to be provided in this section is the name and address of the legal representative who is the applicant under 37 CFR
`
`
`
`
`
`1.43; or the name and address of the assignee, person to whom the inventor is under an obligation to assign the invention, or person
`
`
`
`
`
`who otherwise shows sufficient proprietary interest in the matter who is the applicant under 37 CFR 1.46. If the applicant is an
`
`
`
`
`
`
`
`applicant under 37 CFR 1.46 (assignee, person to whom the inventor is obligated to assign, or person who otherwise shows sufficient
`
`
`
`
`
`
`
`proprietary interest) together with one or more joint inventors, then the joint inventor or inventors who are also the applicant should be
`
`identified in this section.
`
`IRemove I
`
`@ Assignee
`0 Person
`
`
`
`to whom the inventor is obligated
`
`under 35 U.S.C.
`
`Clear
`
`
`
`proprietary interest
`
`
`
`If applicant is the legal representative, indicate the authority to file the patent application, the inventor is:
`
`
`
`I I
`l oLegal Representative 117 lo Joint Inventor
`
`to assign. 10 Person who shows sufficient
`
`
`
`
`
`
`
`
`
`
`
`
`
`I
`
`I
`
`: I
`
`Name of the Deceased or Legally Incapacitated Inventor
`If the Applicant is an Organization check here. [81
`
`
`
`
`
`Name IST-Ericsson
`
`Organization
`
`SA
`
`
`
`Mailing Address Information For Applicant:
`
`
`
`Address 1
`
`39 Chemin du Champ-des-Filles
`
`Address 2
`
`City
`
`Country i I CH
`
`Phone Number
`
`Email Address
`
`Plan-Les-Quates State/Province
`
`Postal Code
`
`CH-1228
`
`Fax Number
`
`
`
`
`
`
`
`
`
`Additional Applicant Data may be generated within this form by selecting
`
`the Add button. IAdd I
`
`
`
`
`
`Assignee Information including Non-Applicant Assignee Information:
`
`
`
`
`
`
`
`
`
`Providing assignment information in this section does not subsitute for compliance with any requirement of part 3 of Title 37 of CFR to
`
`
`
`
`
`
`
`
`
`have an assignment recorded by the Office.
`
`Assignee 1
`
`Complete this section if assignee information, including non-applicant assignee information, is desired to be included on the patent
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`application publication . An assignee-applicant identified in the "Applicant Information" section will appear on the patent application
`
`
`
`
`
`
`
`
`publication as an applicant. For an assignee-applicant, complete this section only if identification as an assignee is also desired on the
`
`
`patent application publication.
`
`
`
`If the Assignee or Non-Applicant Assignee is an Organization check here.
`
`
`
`
`
`
`
`I Remove I
`□
`
`EFS Web 2.2.12
`
`IPR2022-00716
`Apple EX1002 Page 9
`
`

`

`PTO/AIN14 (07-14)
`
`
`Approved for use through 04/3012017. 0MB 0651-0032
`
`
`
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`
`
`
`
`
`Under the Paperwork Reduction Act of 1995, no persons are required lo respond to a collection of information unless it contains a valid 0MB control number.
`
`
`
`
`
`
`
`
`Application Data Sheet 37 CFR 1.76
`
`
`Attorney Docket Number 0112-301/C03308 US1
`
`
`
`Application Number
`
`
`Title of Invention
`
`Reconfigurable Output Stage
`
`Prefix
`
`Given Name
`
`Middle Name
`
`Family Name
`
`Suffix
`
`
`
`Mailing Address Information For Assignee including Non-Applicant Assignee:
`
`
`
`
`
`
`
`
`
`Address 1
`
`Address 2
`
`City
`Country i I
`Phone Number
`
`Email Address
`
`I
`
`State/Province
`
`Postal Code
`
`Fax Number
`
`
`
`
`
`Additional Assignee or Non-Applicant Assignee Data may be generated within this form by
`
`
`
`
`
`
`
`selecting the Add button.
`
`Add
`
`I
`
`I
`
`Remove
`
`Signature:
`
`
`
`
`
`NOTE: This form must be signed in accordance with 37 CFR 1.33. See 37 CFR 1.4 for signature requirements and
`
`
`certifications.
`
`/stevenmdubois/
`Signature
`First Name Steven I Last Name I duBois
`
`Date (YYYY-MM-DD) 2015-11-09
`
`
`
`Registration Number 35023
`
`
`
`
`
`
`
`
`
`Additional Signature may be generated within this form by selecting the Add button.
`
`
`
`IAdd I
`
`This collection of information is required by 37 CFR 1.76. The information is required to obtain or retain a benefit by the public which
`
`
`
`
`
`
`
`
`
`
`
`
`
`is to file (and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This
`
`
`
`
`
`
`
`
`
`
`collection is estimated to take 23 minutes to complete, including gathering, preparing, and submitting the completed application data
`
`
`
`
`sheet form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time you require to
`
`
`
`
`
`
`
`
`complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and
`
`
`
`
`
`Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR
`
`
`
`
`
`COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`
`EFS Web 2.2.12
`
`IPR2022-00716
`Apple EX1002 Page 10
`
`

`

`
`
`Privacy Act Statement
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your submission of the attached form related to
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`a patent application or patent. Accordingly, pursuant to the requirements of the Act, please be advised that: (1) the general authority for the collection
`
`
`
`
`
`
`
`
`
`of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary; and (3) the principal purpose for which the information is
`
`
`
`
`
`
`used by the U.S. Patent and Trademark Office is to process and/or examine your submission related to a patent application or patent. If you do not
`
`
`
`
`
`
`furnish the requested in